BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26283593)

  • 1. Therapeutic anti-NLGP monoclonal antibody for carcinoembryonic antigen expressing tumors is nontoxic to Swiss and BALB/c mice.
    Das A; Mondal B; Bose A; Biswas J; Baral R; Pal S
    Int Immunopharmacol; 2015 Sep; 28(1):785-93. PubMed ID: 26283593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
    Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
    J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
    Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
    Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine carcinoma expressing carcinoembryonic antigen-like protein is restricted by antibody against neem leaf glycoprotein.
    Das A; Barik S; Bose A; Roy S; Biswas J; Baral R; Pal S
    Immunol Lett; 2014 Nov; 162(1 Pt A):132-9. PubMed ID: 25128841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation.
    Sarkar K; Bose A; Chakraborty K; Haque E; Ghosh D; Goswami S; Chakraborty T; Laskar S; Baral R
    Vaccine; 2008 Aug; 26(34):4352-62. PubMed ID: 18590789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
    Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
    Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen.
    Sarkar K; Bose A; Laskar S; Choudhuri SK; Dey S; Roychowdhury PK; Baral R
    Int Immunopharmacol; 2007 Mar; 7(3):306-12. PubMed ID: 17276888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
    Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
    Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.
    Goswami S; Bose A; Sarkar K; Roy S; Chakraborty T; Sanyal U; Baral R
    Vaccine; 2010 Feb; 28(5):1241-52. PubMed ID: 19969119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory.
    Haque E; Mandal I; Pal S; Baral R
    Immunopharmacol Immunotoxicol; 2006; 28(1):33-50. PubMed ID: 16684666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.
    Li GP; Zhang H; Zhu CM
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production.
    Sarkar K; Bose A; Haque E; Chakraborty K; Chakraborty T; Goswami S; Ghosh D; Baral R
    Int Immunopharmacol; 2009 Jun; 9(6):753-60. PubMed ID: 19285575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
    Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
    PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.
    Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R
    Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.